Opko Health (OPK) Cost of Revenue (2010 - 2026)

Opko Health has reported Cost of Revenue for 17 years, with the latest figure at $78.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 26.92% year-over-year to $78.4 million; the trailing twelve-month figure through Mar 2026 stood at $372.0 million (down 26.03% YoY), and the FY2025 full-year result was $400.9 million, down 18.94% from the prior year.
• Cost of Revenue for Q1 2026 stood at $78.4 million, down from $84.4 million in the prior quarter.
• The five-year high for Cost of Revenue was $470.7 million in Q4 2023, with the low at $20.3 million in Q3 2022.
• Historically, Cost of Revenue has averaged $117.4 million across 5 years, with a median of $104.6 million in 2025.
• The largest YoY upside for Cost of Revenue was 823.93% in 2022 against a maximum downside of 91.61% in 2022.
• Opko Health's Cost of Revenue stood at $194.8 million in 2022, then soared by 141.66% to $470.7 million in 2023, then tumbled by 71.63% to $133.5 million in 2024, then plunged by 36.76% to $84.4 million in 2025, then fell by 7.09% to $78.4 million in 2026.
• The last three Cost of Revenue figures came in at $78.4 million (Q1 2026), $84.4 million (Q4 2025), and $101.8 million (Q3 2025), per Business Quant data.